Osteoprotegerin as a Potential Biomarker for Breast Cancer: A Study of Its Relationship with Bone Health, vitamin D, and Calcium Levels.

Asian Pac J Cancer Prev · 2025 · PMC12882004 · PMID 40952296

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Table 2 and Figure 2 demonstrate a highly significant reduction in 25-hydroxyvitamin D levels in breast cancer patients, particularly in the newly diagnosed group (G2), compared with the control group (G1).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.